SCHEMBL314446

SCHEMBL314446

[O]Cc1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL150607 0.79
SCHEMBL1309332 0.78
SCHEMBL559559 0.77 TAAR1 (0.56)
SCHEMBL2030841 0.77 TAAR1 (0.71)
SCHEMBL919641 0.75
SCHEMBL1972145 0.74
SCHEMBL633673 0.74
SCHEMBL286875 0.74
SCHEMBL921269 0.74 TAAR1 (0.59)
SCHEMBL93009 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 899 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108440591-B Synthesis method of chiral dihydrosilane compound 浙江大学 2021-03-05 CN claimed
CN-107624113-B Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of HBsAg (HBV surface antigen) and HBV DNA production for the treatment of hepatitis B virus infection 豪夫迈·罗氏有限公司 2020-10-23 CN claimed
CN-110112465-A Electrolyte for battery with lithium-rich manganese-based positive electrode material system and lithium ion battery 东莞东阳光科研发有限公司 2019-08-09 CN claimed
US-20190010159-A1 NOVEL KINASE INHIBITOR AGAINST WILD-TYPE AND MUTANT EGFR PRECEDO PHARMACEUTICALS CO., LTD (CN) 2019-01-10 US claimed
EP-3398950-A1 NOVEL KINASE INHIBITOR AGAINST WILD-TYPE EGFR AND MUTATED EGFR Precedo Pharmaceuticals Co., Ltd. (CN) 2018-11-07 EP claimed
EP-2731436-B1 2-(PYRROLO[2,3-B]PYRIDINE-5-YL)-2-(T-BUTOXY)-ACETIC ACID DERIVATIVES AS HIV REPLICATION INHIBITORS FOR THE TREATMENT OF AIDS VIIV HEALTHCARE UK LTD (GB) 2017-03-08 EP claimed
US-9163023-B2 Compounds and methods for treating HIV VIIV HEALTHCARE UK LIMITED (GB) 2015-10-20 US claimed
US-20150191469-A1 COMPOUNDS AND METHODS FOR TREATING HIV VIIV HEALTHCARE UK LIMITED (GB) 2015-07-09 US claimed
EP-2877468-A1 COMPOUNDS AND METHODS FOR TREATING HIV VIIV Healthcare UK Limited (GB) 2015-06-03 EP claimed
US-9029391-B2 Isoquinoline compounds and methods for treating HIV VIIV HEALTHCARE UK LIMITED (GB) 2015-05-12 US claimed
US-5262416-A Insecticides or fungicides BAYER AKTIENGESELLSCHAFT (DE) 1993-11-16 US claimed
US-5244865-A Herbicides BAYER AKTIENGESELLSCHAFT (DE) 1993-09-14 US claimed
WO-1992017475-A1 HETEROCYCLIC-CYCLIC AMINE DERIVATIVES PFIZER INC. (US) 1992-10-15 WO claimed
EP-0508954-A1 Receiving element for thermal transfer printing CIBA-GEIGY AG (CH) 1992-10-14 EP claimed
EP-0441517-A2 Tricyclic amines as novel cholinesterase inhibitors PFIZER INC. (US) 1991-08-14 EP claimed
EP-0439785-A2 Substituted 2-[6-(pyrimidinyl)-indol-1-yl]-acrylic acid ester BAYER AG (DE) 1991-08-07 EP claimed
US-4530925-A Aminocyclopentane esters and pharmaceutical formulations GLAXO GROUP LIMITED (GB) 1985-07-23 US claimed
EP-0127930-A2 Aminocyclopentane esters and their preparation and pharmaceutical formulation GLAXO GROUP LIMITED (GB) 1984-12-12 EP claimed
US-4440682-A Stereospecific synthesis of isocephalosporins and 2-oxa isocephalosporins LABORATORIO FARMACEUTICO QUIMICO "LAFARQUIM, S.A." (ES) 1984-04-03 US claimed
US-4265882-A Sulphur analogs of penicillins having a nucleophile substituted in the 6 and 7 position, respectively MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1981-05-05 US claimed